About the University of Chicago Comprehensive
Cancer Center

The Gwen and Jules Knapp Center for Biomedical Discovery is one of the UCCCC’s dedicated state-of-the-art research facilities.

The University of Chicago Comprehensive Cancer Center (UCCCC), comprised of over 200 renowned scientists and physician scientists, engages in a collaborative research program to improve cancer prevention, screening, and treatment. The UCCCC, one of only two National Cancer Institute-designated Comprehensive Cancer Centers in Illinois, has a reputation for excellence, innovation, and a commitment to bringing patients new hope through novel treatments. For almost 40 years, the UCCCC has been a leader in research, with its scientists and clinicians who are transforming cancer care and prevention.

The UCCCC’s mission is to explore and develop innovative ways to prevent cancer and reduce its effects by:

  • Meeting the needs of patients;
  • Performing research of the highest quality;
  • Supporting local physicians and providing education for health professionals; and
  • Engaging the community to increase public awareness of cancer research and the benefits of participating in clinical trials.

UCCCC scientists are performing basic and clinical cancer research and transforming scientific breakthroughs to patients through state-of-the-art treatments and procedures. The UCCCC research programs have pioneered studies in the molecular genetics of cancer, cancer immunology, bone marrow transplantation, hormone therapy, and advanced imaging techniques.

Clinical researchers are testing new concepts discovered in the laboratory and making critical breakthroughs in cancer diagnostics and treatment. The UCCCC is also committed to cancer control, prevention, and population research. Through interactions with local communities, the UCCCC encourages residents to adopt healthier lifestyles and strives to eliminate health disparities among ethnic and social groups.